Dyadic
About Dyadic
Investor Information
News and Media
Careers
Technology Platform
Genomic Products & Services
Enzymes
Manufacturing Services

 





Treasure Coast Business Journal
August 2010
Mark Emalfarb of Dyadic International - R&D Powerhouses Never Gives Up

The Palm Beach Post Money
December 2009
Best, worst performers of 2009 for Palm Beach County and Treasure Coast

TCPalm.com
November 2009
Future is sweet for Jupiter CEO

RENEWABLE ENERGY MAGAZINE
October 2009
INTERVIEW: Mark Emalfarb, CEO of biofuel innovator, Dyadic International

Florida Trend
September 2009
A Matter of Chemistry

Interviews of Mark Emalfarb at the Sixth Annual World Congress on Industrial Biotechnology & Bioprocessing
August 2009
View Video

South Florida Business Journal
May 2009
Dyadic CEO Makes A Comeback, Company sues prominent legal and accounting firms

Ethanol Producer Magazine
January 2007
Enabling the Biorefinery Concept

Ethanol Producer Magazine
January 2007
The Discoverer's Game

BusinessWeek
December 2006
Put A Termite In Your Tank

Nature
[registration required]
Vol. 444, 7 December 2006
A Field in Ferment

Entrepreneur
December 2006
Dyadic Snapshot -- Good Genes

Chicago Tribune
October 13, 2006
Beyond corn: Ethanol's next generation:
Scientists seek cheap, plentiful energy alternatives

Ethanol Today
October 2006
Cellulosic Ethanol: Harvesting the Potential

Distillers Grains Quarterly
Coproduct Breakdown

Society for Industrial Microbiology Annual Industrial Microbiology and Biotechnology Meeting
August 1, 2006, Baltimore, Maryland
Presentation by Richard Burlingame, Ph.D.


BIO Third Annual World Congress on Industrial Biotechnology and Bioprocessing
July 13, 2006, Toronto, Canada
Presentation by Dyadic's scientist, Marco Baez, Ph.D.


U.S. Department of Agriculture
Ethanol Production from Alkaline Peroxide Pretreated Enzymatically Saccharified Wheat Straw


BioPharm International
Maximizing Protein Expression in Filamentous Fungi


ETHANOL: DOE lays out research plan for cellulosic fuel production
Read Press Release
Breaking the Biological Barriers to Cellulosic Ethanol: A Joint Research Agenda (Full Report)
For information regarding News and Media please contact investors@dyadic.com


 
Dyadic International Stockholder Class Action Lawsuit Resolved

Jupiter, Fla.

April 19, 2010

Dyadic International, Inc. (Pink Sheets:DYAI) (“Dyadic”) announced today an agreement to resolve the consolidated stockholder class action lawsuit against Dyadic and certain of its current and former officers and directors which was initially filed in October 2007.

The litigation, Miller v. Dyadic International, Inc. et al, pending in the United States District Court for the Southern District of Florida, asserted class action claims under federal securities laws based on allegations of misstatements and omissions by Dyadic and certain of its current and former officers and directors arising out of alleged improprieties at Dyadic’s Asian subsidiaries. The final settlement of this lawsuit is conditioned upon the approval of a Stipulation of Settlement which has been submitted by the parties to the Court. The Stipulation of Settlement provides for payment to the alleged class of $4.8 million in cash to be funded by Dyadic and its insurance carriers. If approved by the Court, the settlement will lead to dismissal of the lawsuit with prejudice. As reported in Dyadic’s consolidated financial statements for the year ended December 31, 2009, Dyadic established a reserve in connection with the class action lawsuit which is adequate to cover the costs associated with resolving this matter.

Mark Emalfarb, President and Chief Executive Officer of Dyadic stated, "While Dyadic and its current and former officers and directors continue to firmly deny all allegations of wrongdoing, we also believe it is in the best interests of Dyadic and its stockholders to eliminate the continuing expense and disruption of litigation to our business and put this matter behind us. Settling this lawsuit removes a significant obstacle for Dyadic and allows us to continue the momentum we have gained over the past eighteen months, enabling us to better apply our resources in continuing to advance and leverage Dyadic’s products and technologies."

About Dyadic
Dyadic is a leading-edge early-stage biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries. Please visit Dyadic’s website at www.dyadic.com.

Cautionary Statement for Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.

Contacts
Dyadic International, Inc.
Adam J. Morgan
Vice President General Counsel & Business Development
Phone: 561-743-8333
Email: amorgan@dyadic.com



Home Contact Site Map Important Legal Notice   Search © Dyadic 2008